Legal Representation
Attorney
Christina M. Licursi, Esq.
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 2, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 2, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 9, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Feb 24, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 9, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 24, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 1, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 30, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 30, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 30, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 28, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 28, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 28, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 27, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 25, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 25, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 25, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 1, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 1, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 1, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 1, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 17, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 29, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 27, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 26, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 26, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 24, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 24, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 24, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 24, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 9, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
Classification
International Classes
005